
Dextroamphetamine - NIST Chemistry WebBook
All mass spectra in this site (plus many more) are available from the NIST/EPA/NIH Mass Spectral Library. Please see the following for information about the library and its accompanying search …
Dextroamphetamine | C9H13N - ChemSpider
ChemSpider record containing structure, synonyms, properties, vendors and database links for Dextroamphetamine, 51-64-9, Dexamfetamine, KWTSXDURSIMDCE-QMMMGPOBSA-N
DEXTROAMPHETAMINE - precision.fda.gov
Chemical Structure Stereochemistry ABSOLUTE Molecular Formula C 9 H 13 N Molecular Weight 135.21
Dextroamphetamine: Mechanisms, Uses, and Implications
Its molecular formula is C105N, which indicates the presence of a benzene ring connected to a propylamine chain. This structure is essential as it contributes to the drug's ability to cross the blood …
dextroamphetamine - PharmGKB
Dexanfetamina [inn-spanish] Dextroamphetamine Dextroamphetamine sulfate S (+)-amphetamine d-1-Phenyl-2-aminopropan [German] Amsustain Dephadren Desoxyn Dexacaps Dexadrine Dexedrine …
DEXTROAMPHETAMINE - National Institutes of Health
Substance Hierarchy Chemical Structure Chemical Moieties Names and Synonyms Codes - Classifications
Compound: DEXTROAMPHETAMINE (CHEMBL612) - ChEMBL
Report card for Compound DEXTROAMPHETAMINE (CHEMBL612). C9H13N, Small molecule, AMFETAMINE, (S)-, AMPHETAMINE, D-, D-AMPHETAMINE, DEXAMFETAMINE, Dexampex, …
Dextroamphetamine - Chemical Compound | PlantaeDB
Learn about the chemical compound Dextroamphetamine, its molar weight, SMILES code, IUPAC, targets (proven or predicted), 2D and 3D structure and so on..
dexamfetamine | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY
Comment: Dextroamphetamine was first approved by the FDA in 1955 as dextroamphetamine resin complex in combination with amphetamine complex. These are box plot that provide a unique …
Dextroamphetamine sulfate | DrugBank
Dextroamphetamine is the dextrorotatory enantiomer of amphetamine 5. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder. 6, 8